Evidence behind the WHO guidelines: Hospital care for children: What is the aetiology and treatment of chronic diarrhoea in children with HIV?

Journal of Tropical Pediatrics

Volumn 55, Issue 6, 2009, Pages 349-355

  Ford, Alasdair ^a   Duke, Trevor ^b   Campbell, Harry ^c  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; CYANOCOBALAMIN; FOLIC ACID; LOPERAMIDE; METRONIDAZOLE; NICOTINIC ACID; NITAZOXANIDE; PAROMOMYCIN; PLACEBO; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE; ZINC;

ARTICLE; ASTROVIRUS; CALORIC RESTRICTION; CD4 LYMPHOCYTE COUNT; CHILD HEALTH CARE; CHRONIC DIARRHEA; CLINICAL TRIAL; COMA; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS; DEATH; DIARRHEA; DRUG DOSE INCREASE; ENTAMOEBA HISTOLYTICA; ENTEROPATHY; ENTEROVIRUS; ERYTHEMA MULTIFORME; ESCHERICHIA COLI; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEUS; MALABSORPTION; MICROSPORIDIA; NEUTROPENIA; NUTRITIONAL SUPPORT; ORAL REHYDRATION THERAPY; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PROTOZOAL INFECTION; RESPIRATION DEPRESSION; RESPIRATORY TRACT INFECTION; SALMONELLA; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VIRUS LOAD; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION;

ANTIDIARRHEALS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DIARRHEA; EVIDENCE-BASED MEDICINE; FEMALE; HIV INFECTIONS; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 73149105956     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp122     Document Type: Article

References (60)

1. UNAIDS. AIDS epidemic update, 2006. http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf.
2. Thea DM, St Louis ME, Atido U, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med 1993;329:1696-702.
3. Pozio E, Rezza G, Boschini A, et al. Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis 1997;176:969-75.
4. Baker J L, Gosland MP, Herrington JD, et al. Cytomegalovirus colitis after 5-fluorouracil and interferon-alpha therapy. Pharmacotherapy 1994;14:246-9.
5. Weber R, Ledergerber B, Zbinden R, et al. Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Arch Intern Med 1999;159:1473-80.
6. Liste MB, Natera I, Suarez JA, et al. Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children. J Clin Microbiol 2000;38:2873-7.
7. Gassama A, Sow PS, Fall F, et al. Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. Int J Infect Dis 2001;5:192-8.
8. Grohmann GS, Glass RI, Pereira HG, et al. Enteric viruses and diarrhea in HIV-infected patients. Enteric opportunistic infections working group. N Engl J Med 1993;329:14-20.
9. Verdier RI, Fitzgerald DW, Johnson WD, Jr, et al. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med 2000;132:885-8.
10. Antony MA, Brandt LJ, Klein RS, et al. Infectious diarrhea in patients with AIDS. Dig Dis Sci 1988; 33:1141-6.
11. Carcamo C, Hooton T, Wener MH, et al. Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru. J Infect Dis 2005;191:11-19.
12. Del Aguila C, Navajas R, Gurbindo D, et al. Microsporidiosis in HIV-positive children in Madrid (Spain). J Eukaryot Microbiol 1997;44:84S-5S.
13. Germani Y, Minssart P, Vohito M, et al. Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Am J Trop Med Hyg 1998;59:1008-14.
14. Mwachari C, Batchelor BI, Paul J, et al. Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. J Infect 1998;37:48-53.
15. Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr 2001;32:550-4.
16. Chintu C, Luo C, Baboo S, et al. Intestinal parasites in HIV-seropositive Zambian children with diarrhoea. J Trop Pediatr 1995;41:149-52.
17. Chokephaibulkit K, Wanachiwanawin D, Tosasuk K, et al. Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. Southeast Asian J Trop Med Public Health 2001; 32:770-5.
18. Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, et al. Cryptosporidiosis and microsporidiosis in Ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hyg 2005;73:921-5.
19. Okongo M, Morgan D, Mayanja B, et al. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998;27:698-702.
20. Fontana M, Zuin G, Mammino A, et al. Rotavirus infection and diarrhea in healthy and HIV-infected children: a cohort study. J Pediatr Gastroenterol Nutr 1996;23:492-6.
21. Oshitani H, Kasolo FC, Mpabalwani M, et al. Association of rotavirus and human immunodeficiency virus infection in children hospitalized with acute diarrhea, Lusaka, Zambia. J Infect Dis 1994; 169:897-900.
22. The Italian Paediatric Intestinal/HIV Study Group. Intestinal malabsorption of HIV-infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. Aids 1993;7:1435-40.
23. Gonzalez GG, Pujol FH, Liprandi F, et al. Prevalence of enteric viruses in human immunodeficiency virus seropositive patients in Venezuela. J Med Virol 1998; 55:288-92.
24. Bartlett JG, Belitsos PC, Sears CL. AIDS enteropathy. Clin Infect Dis 1992;15:726-35.
25. Guarino A, Bruzzese E, De Marco G, et al. Management of gastrointestinal disorders in children with HIV infection. Paediatr Drugs 2004; 6:347-62.
26. Kaplan JE. Diagnosis, treatment, and prevention of selected common HIV-related opportunistic infections in the Caribbean region. Top HIV Med 2004;12:136-41.
27. Edwards P, Wodak A, Cooper DA, et al. The gastrointestinal manifestations of AIDS. Aust N Z J Med 1990;20:141-8.
28. Keusch GT. Malnutrition, infection, and immune function. In: Suskind RM, Lewinter-Suskind L (eds). The malnourished child. Vol. 19 of the Nestle Nutrition workshop series. Vevey, Switzerland: Nestle Nutrition, 1990, 37-55.
29. Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996;348:379-83.
30. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 2001;184:103-6.
31. Rossignol JF, Hidalgo H, Feregrino M, et al. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998;92:663-6.
32. Doumbo O, Rossignol JF, Pichard E, et al. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg 1997;56:637-9.
33. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002;360:1375-80.
34. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001;184:381-4.
35. Ortiz JJ, Ayoub A, Gargala G, et al. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment Pharmacol Ther 2001;15:1409-15.
36. Ramos-Soriano AG, Saavedraa JM, Wu T, et al. Enteric pathogens associated with gastrointestinal dysfunction in children with HIV infection. Mol Cell Probes 1996;10:67-73.
37. Pape JW, Verdier RI, Boncy M, et al. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Intern Med 1994;121:654-7.
38. Coutsoudis A, Pillay K, Spooner E, et al. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa. S Afr Med J 2005;95:339-45.
39. Rieder MJ, King SM, Read S. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection. Pediatr Infect Dis J 1997;16:1028-31.
40. Hewitt RG, Yiannoutsos CT, Higgs ES, et al. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis 2000;31:1084-92.
41. White AC Jr, Chappell CL, Hayat CS, et al. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis 1994;170:419-24.
42. Bissuel F, Cotte L, Rabodonirina M, et al. Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis 1994;18:447-9.
43. Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 2005;366:1862-7.
44. Baqui AH, Black RE, El Arifeen S, et al. Zinc therapy for diarrhoea increased the use of oral rehydration therapy and reduced the use of antibiotics in Bangladeshi children. J Health Popul Nutr 2004;22:440-2.
45. Bhandari N, Mazumder S, Taneja S, et al. A pilot test of the addition of zinc to the current case management package of diarrhea in a primary health care setting. J Pediatr Gastroenterol Nutr 2005;41:685-7.
46. Fawzi WW, Msamanga GI, Wei R, et al. Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child's morbidity and CD4 cell counts. Clin Infect Dis 2003;36:1053-62.
47. Rollins NC, van den Broeck J, Kindra G, et al. The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea. Acta Paediatr 2007;96:62-8.
48. Pozio E. Highly active antiretroviral therapy and opportunistic protozoan infections. Parassitologia 2004;46:89-93.
49. Carr A, Marriott D, Field A, et al. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998 351:256-61.
50. Foudraine NA, Weverling GJ, van Gool T, et al. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. Aids 1998;12:35-41.
51. Maggi P, Larocca AMV, Quarto M, et al. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 2000;19:213-17.
52. WHO. World Health Organization. The rational use of drugs in the management of acute diarrhoea in children Geneva: World Health Organization, 1992.
53. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996;97:424-35.
54. Katabira ET. Epidemiology and management of diarrheal disease in HIV-infected patients. Int J Infect Dis 1999;3:164-7.
55. Abboud P, Lemée V, Gargala G, et al. Successful treatment of metronidazole-and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2001;32:1792-4.
56. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001;14:114-28.
57. Gilles HM, Hoffman PS. Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol 2002;18:95-7.
58. Harp JA, Whitmire WM, Sacco R. In vitro proliferation and production of gamma interferon by murine CD4c cells in response to Cryptosporidium parvum antigen. J Parasitol 1994;80:67-72.
59. Rehg JE. Effect of interferon in experimental Cryptosporidium parvum infection. J Infect Dis 1996;174:229-232.
60. Jokipii L, Jokipii AM. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med 1986;315:1643 7.